SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 77.08 |
| Enterprise Value ($M) | 46.05 |
| Book Value ($M) | 10.22 |
| Book Value / Share | 0.36 |
| Price / Book | 7.54 |
| NCAV ($M) | -13.88 |
| NCAV / Share | -0.49 |
| Price / NCAV | -5.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.25 |
| Return on Assets (ROA) | -0.82 |
| Return on Equity (ROE) | -3.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.70 |
| Current Ratio | 3.75 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 36.26 |
| Assets | 60.36 |
| Liabilities | 50.14 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.88 |
| Operating Income | -23.25 |
| Net Income | -60.66 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -20.71 |
| Cash from Investing | -0.51 |
| Cash from Financing | 20.43 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | AWM Investment Company, Inc. | 10.00 | 118.71 | |
| 13G/A | Bio-rad Laboratories, Inc. | 9.70 | 82.94 | |
| 13D/A | Broadwood Partners, L.p. | 40.20 | 127.60 | |
| 13G/A | Smith Patrick W | 10.50 | ||
| 13G | Pura Vida Investments, Llc | 4.57 | -12.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,514 | 32,465 | 47.79 | |
| 1,421 | 16,728 | 8.49 | |
| 18,252 | 49,323 | 37.01 | |
| 12,677 | 60,597 | 20.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NRXP – NRx Pharmaceuticals, Inc. | NVCT – Nuvectis Pharma, Inc. |
| OCGN – Ocugen, Inc. | OKYO – OKYO Pharma Limited |
| ONCO – Onconetix, Inc. |
Financial data and stock pages provided by
Fintel.io